Oncology Research

Papers
(The median citation count of Oncology Research is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Retraction notice to Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184 [Oncology Research 26(2) (2018) 297-305]36
Galectins dysregulation: A way for cancer cells to invade and pervade26
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities24
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer21
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP121
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells21
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations20
lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition19
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany19
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma18
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis18
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway17
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer17
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data16
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells16
Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms15
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis14
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?13
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells13
Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network13
The role of LIN28B in tumor progression and metastasis in solid tumor entities12
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas11
MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783]11
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer11
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells10
Erratum: Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells10
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance10
Retraction notice to High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells [Oncology Research 27(9) (2019) 102510
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma10
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells10
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials10
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study10
Deoxynortryptoquivaline: A unique antiprostate cancer agent10
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer9
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells9
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker9
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study8
Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma8
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer8
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways8
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma7
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma7
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer7
The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models7
Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma7
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment7
Progress in research on tumor microenvironment-based spatial omics technologies7
COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging7
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma7
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis6
Erratum6
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer6
Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc6
The SMAD2/miR-4256/HDAC5/p16INK4a signaling axis contributes to gastric cancer progression6
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study6
Retraction notice to Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the -Catenin Pathway [Oncology Research 25(8) (2017) 1376
Retraction notice to Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma [Oncology Research 26(3) (2018) 335343]6
Erratum6
Erratum: MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression6
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription6
Erratum6
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab6
Retraction notice to MicroRNA-204 Inhibits the Growth and Motility of Colorectal Cancer Cells by Downregulation of CXCL8 [Oncology Research 26(8) (2018) 12951305]6
Tumor neoantigens: Novel strategies for application of cancer immunotherapy5
circRNAs in drug resistance of breast cancer5
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer5
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape5
Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway5
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes5
Retraction notice to miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein [Oncology Research 26(7) (2018) 11131121]5
0.040085077285767